The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.

Published in: BMC cancer (2019)

TET2 mutation had adverse impacts on survival and treatment response in AML patients and will contribute to risk-stratification, prognosis prediction and therapy guidance.

Keyphrases

acute myeloid leukemia
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
allogeneic hematopoietic stem cell transplantation
prognostic factors
emergency department
electronic health record